WHO ICTRP trial
Safety and efficacy of photodynamic therapy (with riboflavin as sensitizer) for…
PACTR201912897645869 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR201912897645869 |
|---|---|
| Public title | Safety and efficacy of photodynamic therapy (with riboflavin as sensitizer) for treatment of malaria in adult Nigerian population |
| Scientific title | Safety and efficacy of photodynamic therapy (with riboflavin as sensitizer) for treatment of malaria in adult Nigerian population: a Phase II study |
| Primary sponsor | Future Minds Development Initiative |
| Secondary sponsors | Weber Medical |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase-2 |
| Countries | Nigeria |
| Conditions | Malaria;Malaria |
| Interventions | Photodynamic Therapy;Oral Artemisin Combination Therapy |
| Registration date | Nov 28, 2019 |
| Target size | 200 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: